Simvastatin ≥98% (durch TLC)

Lieferant: ENZO LIFE SCIENCES AG

ENZOBMLG2440050EA 183 CHF
ENZOBMLG2440050 ENZOBMLG2440250
Simvastatin ≥98% (durch TLC)
Simvastatin

HMG-CoA reductase inhibitor


HMG-CoA reductase inhibitor. Synthetic analog of Lovastatin (Prod. No. BML-G226). Inhibits the biosynthesis of isoprenoids and prevents small G protein activation. Displays lipid lowering and antihypertensive effects. Displays antiinflammatory, immunomodulatory effects as well as protective effects in experimental traumatic brain injury. Activates Rac1-dependent signalling pathway.

Formel: C25H38O5
MW: 418,57 g/mol
MDL Number: MFCD00072007
CAS-Nummer: 79902-63-9
https://ch.vwr.com/stibo/web/std.lang.all/38/89/45403889.jpg

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Mehr About VWR